Benjamin P. Saylor is associate editor of Urology Times, an Advanstar Communications publication.
How rBCG EAP could open up access for Anktiva in bladder cancer
April 11th 2025“I feel a lot of providers, with Antiva being available, have unfortunately reserved use of this great FDA-approved agent for BCG-unresponsive patients because of the supply issue with BCG," says Suzanne B. Merrill, MD, FACS.
How pre-URS tamsulosin use in pediatric patients may reduce repeat procedures
April 8th 2025“I would say the take-home message for this study is that prescribing tamsulosin for a week prior to an anticipated surgery that involves flexible ureteroscopy is a very simple practice that certainly is within standard of care within pediatric urology," says Kate H. Kraft, MD, MHPE, FACS, FAAP.
Raymond Xu, MD, discusses Cost Plus Drugs and urogynecologic medications
April 7th 2025“When I talk to physicians outside of urology, as well as within urology, much of the hesitation with using Cost Plus Drugs is that it seems complicated to use, when in reality, the process is actually very simple," says Raymond Xu, MD.
Expert discusses innovations in single-use ureteroscopes for stones
April 7th 2025"A lot of people are using [single-use ureteroscopes] nowadays, and part of it is because it really enhances our ability to provide guaranteed care, because we don't have to rely on the reusability of scopes," says Perry Xu, MD.
Dr Louise Kostos on the rapidly evolving prostate cancer treatment landscape
March 29th 2025“I think we now have really robust data showing that earlier treatment intensification with combination regimens does lead to improved survival for patients with metastatic hormone-sensitive prostate cancer," says Dr Louise Kostos.
What a long-term study of patients undergoing RARC reveals about upstaging
March 25th 2025“High risk, non–muscle invasive bladder cancer carries a significant risk of recurrence and progression. This emphasizes the need for careful patient selection, especially when we are considering bladder-sparing approaches," says Neeraja Tillu, MD.